EP-1678: Quality of radiotherapy services in post-Soviet countries: an IAEA survey

E. Rosenblatt, E. Fidarova, Sunita Ghosh, Olga Unterkirhere, N. Semikoz, V. Sinaika, V. Kim, Nerses Karamyan, I. Isayev, K. Akbarov

10 more authors

D. Lomidze, Oksana Bondareva, P. Tuzlucov, Manzura Zardodkhonova, S. Tkachev, M. Kislyakova, J. Alimov, T. Pidlubna, Michael Bernard Barton, W. Mackillop

2018

Full text Open access: Hybrid Metadata (CSL-JSON)

DOI 10.1016/s0167-8140(18)31987-x

Data confidence 70 medium

How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

We found that clinical trials involving more than one institution were associated with a better publication rate.Trials funding in radiotherapy should take this result into account to better optimize human and economic resources.Non-publication means a poor use of financial resources, a loss of knowledge through hidden data, and poses an ethical issue with our patient community.